Literature DB >> 24354755

Clinical immobilization techniques for proton therapy.

Andrew J Wroe1, David A Bush2, Reinhard W Schulte2, Jerry D Slater2.   

Abstract

Proton therapy through the use of the Bragg peak affords clinicians a tool with which highly conformal dose can be delivered to the target while minimizing integral dose to surrounding healthy tissue. To gain maximum benefit from proton therapy adequate patient immobilization must be maintained to ensure accurate dose delivery. While immobilization in external beam radiation therapy is designed to minimize inter- and intra-fraction target motion, in proton therapy there are other additional aspects which must be considered, chief of which is accurately determining and maintaining the targets water-equivalent depth along the beam axis. Over the past 23 years of treating with protons, the team at the James M. Slater Proton Treatment and Research Center at Loma Linda University Medical Center have developed and implemented extensive immobilization systems to address the specific needs of protons. In this publication we review the immobilization systems that are used at Loma Linda in the treatment of head and neck, prostate, upper GI, lung and breast disease, along with a description of the intracranial radiosurgery immobilization system used in the treatment of brain metastasis and arteriovenous malformations (AVM's).
© The Author(s) 2014.

Entities:  

Keywords:  Immobilization.; Proton therapy

Mesh:

Year:  2014        PMID: 24354755     DOI: 10.7785/tcrt.2012.500398

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  8 in total

Review 1.  Artificial intelligence in radiotherapy.

Authors:  Sarkar Siddique; James C L Chow
Journal:  Rep Pract Oncol Radiother       Date:  2020-05-06

2.  Proton stereotactic body radiation therapy for liver metastases-results of 5-year experience for 81 hepatic lesions.

Authors:  Alex R Coffman; Daniel C Sufficool; Joseph I Kang; Chung-Tsen Hsueh; Sasha Swenson; Patrick Q McGee; Gayathri Nagaraj; Baldev Patyal; Mark E Reeves; Jerry D Slater; Gary Y Yang
Journal:  J Gastrointest Oncol       Date:  2021-08

3.  Individualized 4-dimensional computed tomography proton treatment for pancreatic tumors.

Authors:  Matthew L Knecht; Ning Wang; April Vassantachart; Rachel Mifflin; Jerry D Slater; Gary Y Yang
Journal:  J Gastrointest Oncol       Date:  2017-08

4.  A phase I trial of Proton stereotactic body radiation therapy for liver metastases.

Authors:  Joseph I Kang; Daniel C Sufficool; Chung-Tsen Hsueh; Andrew J Wroe; Baldev Patyal; Mark E Reeves; Jerry D Slater; Gary Y Yang
Journal:  J Gastrointest Oncol       Date:  2019-02

5.  Long-time clinical experience in patient setup for several particle therapy clinical indications: management of patient positioning and evaluation of setup reproducibility and stability.

Authors:  Rosalinda Ricotti; Andrea Pella; Barbara Tagaste; Giovanni Elisei; Giulia Fontana; Maria Bonora; Mario Ciocca; Francesca Valvo; Roberto Orecchia; Guido Baroni
Journal:  Br J Radiol       Date:  2019-11-14       Impact factor: 3.629

Review 6.  Proton and Heavy Particle Intracranial Radiosurgery.

Authors:  Eric J Lehrer; Arpan V Prabhu; Kunal K Sindhu; Stanislav Lazarev; Henry Ruiz-Garcia; Jennifer L Peterson; Chris Beltran; Keith Furutani; David Schlesinger; Jason P Sheehan; Daniel M Trifiletti
Journal:  Biomedicines       Date:  2021-01-03

Review 7.  Management of Motion and Anatomical Variations in Charged Particle Therapy: Past, Present, and Into the Future.

Authors:  Julia M Pakela; Antje Knopf; Lei Dong; Antoni Rucinski; Wei Zou
Journal:  Front Oncol       Date:  2022-03-09       Impact factor: 6.244

8.  A phase II trial of gemcitabine and erlotinib followed by ChemoProton therapy plus capecitabine and oxaliplatin for locally advanced pancreatic cancer.

Authors:  Samrat M Sanghvi; Alex R Coffman; Chung-Tsen Hsueh; Joseph Kang; Annie Park; Naveenraj L Solomon; Carlos A Garberoglio; Mark E Reeves; Jerry D Slater; Gary Y Yang
Journal:  J Gastrointest Oncol       Date:  2022-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.